申请人:Boehringer Ingelheim International GmbH
公开号:US08178568B2
公开(公告)日:2012-05-15
Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
本发明揭示了调节CB2受体的化合物。本发明的化合物与CB2受体结合并作为激动剂,对于治疗炎症具有用处。那些作为激动剂的化合物还可用于治疗疼痛。